Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-25-006664·DG Capital Management, LLC
Schedule 13G ownership disclosure
Fennec Pharmaceuticals Inc
Common Shares · CUSIP: 31447P100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- DG Capital Management, LLC
Shares: 1,114,692.00 · Class: 4.1%
- DG Value Partners II Master Fund, LP
Shares: 953,407.00 · Class: 3.5%
- Dov Gertzulin
Shares: 1,114,692.00 · Class: 4.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006664
- Form type
- SCHEDULE 13G/A
- Filer
- DG Capital Management, LLC
- CIK
- CIK 1512716
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership